Orchestra BioMed Holdings (OBIO) EBITDA Margin (QoQ) (2022 - 2026)
Orchestra BioMed Holdings (OBIO) EBITDA Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.01 Mn |
| Dec 31, 2025 | 238,108.00 |
| Sep 30, 2025 | -4,739.00 |
| Jun 30, 2025 | -13,200.00 |
| Mar 31, 2025 | 441,186.00 |
| Dec 31, 2024 | -493,598.00 |
| Sep 30, 2024 | 51,124.00 |
| Jun 30, 2024 | 15,932.00 |
| Mar 31, 2024 | 243,745.00 |
| Dec 31, 2023 | -129,739.00 |
| Sep 30, 2023 | -205,039.00 |
| Jun 30, 2023 | -42,412.00 |
| Mar 31, 2023 | -10,081.00 |
| Dec 31, 2022 | -2,542.00 |
| Sep 30, 2022 | 103,813.00 |
| Jun 30, 2022 | -131,159.00 |